Iranian Journal of Pediatrics

Published by: Kowsar

DAT1 Gene Polymorphism in Children with Attention Deficit Hyperactivity Disorder

Seyed - Mahmoud Tabatabaei 1 , 2 , * , Shahrokh Amiri 2 , Nasrin Forghani 2 , Seyed - Gholamreza Noorazar 2 , Shahin Abdollahi - Fakhim 3 , Habibeh Barzegar 2 and Mir - Mahmoud Mirnasab 4
Authors Information
1 Department of Physiology, Tabriz Branch, Islamic Azad University, Tabriz, Iran
2 Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Otolaryngology - Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran
4 Department of Education, Faculty of Education and Psychology, University of Tabriz, Tabriz, Iran
Article information
  • Iranian Journal of Pediatrics: June 2018, 28 (3); e13544
  • Published Online: May 16, 2018
  • Article Type: Research Article
  • Received: May 16, 2017
  • Revised: February 6, 2018
  • Accepted: March 4, 2018
  • DOI: 10.5812/ijp.13544

To Cite: - Mahmoud Tabatabaei S, Amiri S, Forghani N, - Gholamreza Noorazar S, Abdollahi - Fakhim S, et al. DAT1 Gene Polymorphism in Children with Attention Deficit Hyperactivity Disorder, Iran J Pediatr. 2018 ;28(3):e13544. doi: 10.5812/ijp.13544.

Abstract
Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Franke B, Vasquez AA, Johansson S, Hoogman M, Romanos J, Boreatti-Hummer A, et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology. 2010;35(3):656-64. doi: 10.1038/npp.2009.170. [PubMed: 19890261]. [PubMed Central: PMC3055604].
  • 2. Stefanatos GA, Baron IS. Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V. Neuropsychol Rev. 2007;17(1):5-38. doi: 10.1007/s11065-007-9020-3. [PubMed: 17318413].
  • 3. Meysamie A, Fard MD, Mohammadi MR. Prevalence of Attention-Deficit/Hyperactivity Disorder Symptoms in Preschool-aged Iranian Children. Iran J Pediatr. 2011;21(4):467-72. [PubMed: 23056833]. [PubMed Central: PMC3446126].
  • 4. Amiri S, Ghoreishizadeh MA, Sadeghi-Bazargani H, Jonggoo M, Golmirzaei J, Abdi S, et al. Prevalence of Adult Attention Deficit Hyperactivity Disorder (Adult ADHD): Tabriz. Iran J Psychiatry. 2014;9(2):83-8.
  • 5. Amiri S, Fakhari A, Maheri M, Mohammadpoor Asl A. Attention deficit/hyperactivity disorder in primary school children of Tabriz, North-West Iran. Paediatr Perinat Epidemiol. 2010;24(6):597-601. doi: 10.1111/j.1365-3016.2010.01145.x. [PubMed: 20955237].
  • 6. Tehrani-Doost M, Shahrivar Z, Pakbaz B, Rezaie A, Ahmadi F. Normative data and psychometric properties of the child behavior checklist and teacher rating form in an Iranian community sample. Iran J Pediatr. 2011;21(3):331-42. [PubMed: 23056810]. [PubMed Central: PMC3446174].
  • 7. Agudelo JA, Galvez JM, Fonseca DJ, Mateus HE, Talero-Gutierrez C, Velez-Van-Meerbeke A. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder. Neurologia. 2015;30(3):137-43. doi: 10.1016/j.nrl.2013.12.005. [PubMed: 24461309].
  • 8. van den Berg SM, Willemsen G, de Geus EJ, Boomsma DI. Genetic etiology of stability of attention problems in young adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(1):55-60. doi: 10.1002/ajmg.b.30251. [PubMed: 16287044].
  • 9. Kuntsi J, Rijsdijk F, Ronald A, Asherson P, Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol Psychiatry. 2005;57(6):647-54. doi: 10.1016/j.biopsych.2004.12.032. [PubMed: 15780852].
  • 10. Larsson JO, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1267-75. doi: 10.1097/01.chi.0000135622.05219.bf. [PubMed: 15381894].
  • 11. Waldman ID, Rhee SH. Behavioral and molecular genetic studies. In: Sandberg S, editor. Hyperactivity and Attention Disorders of Childhood. 2nd ed. New York: Wiley; 2002. p. 290-335.
  • 12. Reiersen AM, Todorov AA. Association between DRD4 genotype and Autistic Symptoms in DSM-IV ADHD. J Can Acad Child Adolesc Psychiatry. 2011;20(1):15-21. [PubMed: 21286365]. [PubMed Central: PMC3024719].
  • 13. Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, D'Souza UM. Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(8):1070-8. doi: 10.1002/ajmg.b.30572. [PubMed: 17579365].
  • 14. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH. Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet. 2001;105(5):471-8. [PubMed: 11449401].
  • 15. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73-93. doi: 10.1146/annurev.ne.16.030193.000445. [PubMed: 8096377].
  • 16. Mick E, Biederman J, Spencer T, Faraone SV, Sklar P. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8):890-4. doi: 10.1002/ajmg.b.30376. [PubMed: 16917950]. [PubMed Central: PMC2715939].
  • 17. Subcommittee on Attention-Deficit/Hyperactivity D, Steering Committee on Quality I, Wolraich M, Brown L, Brown RT.Management, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007-22. doi: 10.1542/peds.2011-2654. [PubMed: 22003063]. [PubMed Central: PMC4500647].
  • 18. Frazer A, Gerhardt GA, Daws LC. New views of biogenic amine transporter function: implications for neuropsychopharmacology. Int J Neuropsychopharmacol. 1999;2(4):305-20. doi: 10.1017/S1461145799001625. [PubMed: 11285147].
  • 19. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev. 1998;26(2-3):148-53. [PubMed: 9651511].
  • 20. Turic D, Swanson J, Sonuga-Barke E. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med. 2010;3:61-78. [PubMed: 23226043]. [PubMed Central: PMC3513209].
  • 21. Muglia P, Jain U, Inkster B, Kennedy JL. A quantitative trait locus analysis of the dopamine transporter gene in adults with ADHD. Neuropsychopharmacology. 2002;27(4):655-62. doi: 10.1016/S0893-133X(02)00328-7. [PubMed: 12377402].
  • 22. Bruggemann D, Sobanski E, Alm B, Schubert T, Schmalzried H, Philipsen A, et al. No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder. Psychiatr Genet. 2007;17(2):121. doi: 10.1097/YPG.0b013e32801231d4. [PubMed: 17413453].
  • 23. Aparecida da Silva M, Cordeiro Q, Louza M, Vallada H. Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients. J Atten Disord. 2011;15(4):305-9. doi: 10.1177/1087054710365989. [PubMed: 20332413].
  • 24. Muller DJ, Chiesa A, Mandelli L, De Luca V, De Ronchi D, Jain U, et al. Correlation of a set of gene variants, life events and personality features on adult ADHD severity. J Psychiatr Res. 2010;44(9):598-604. doi: 10.1016/j.jpsychires.2009.11.011. [PubMed: 20006992].
  • 25. Yu CJ, Du JC, Chiou HC, Feng CC, Chung MY, Yang W, et al. Sugar-Sweetened Beverage Consumption Is Adversely Associated with Childhood Attention Deficit/Hyperactivity Disorder. Int J Environ Res Public Health. 2016;13(7). doi: 10.3390/ijerph13070678. [PubMed: 27384573]. [PubMed Central: PMC4962219].
  • 26. Brown AB, Biederman J, Valera E, Makris N, Doyle A, Whitfield-Gabrieli S, et al. Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks. Psychiatry Res. 2011;193(1):7-16. doi: 10.1016/j.pscychresns.2011.01.006. [PubMed: 21596533]. [PubMed Central: PMC3105199].
  • 27. Barkley RA, Smith KM, Fischer M, Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(5):487-98. doi: 10.1002/ajmg.b.30326. [PubMed: 16741944]. [PubMed Central: PMC2562041].
  • 28. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, et al. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1576-9. doi: 10.1002/ajmg.b.30861. [PubMed: 18802924].
  • 29. Sharif F, Zarei S, Alavi Shooshtari A, Vossoughi M. The Effect of Stress Management Program Using Cognitive Behavior Approach on Mental Health of the Mothers of the Children With Attention Deficit Hyperactivity Disorder. Iran J Pediatr. 2015;25(3). e474. doi: 10.5812/ijp.25(3)2015.474. [PubMed: 26199709]. [PubMed Central: PMC4505991].
  • 30. Arabgol F, Panaghi L, Nikzad V. Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder. Iran J Pediatr. 2015;25(1). e265. doi: 10.5812/ijp.265. [PubMed: 26199694]. [PubMed Central: PMC4505976].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments